购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-15 (Compound 6) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,展现出对白三烯 B3 和雌二醇的卓越抑制活性,IC50 值分别达到 ≤ 1 μM 和 ≤ 0.1 μM。该化合物主要应用于肝病、代谢性和心血管疾病的研究领域,特别适用于非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)或药物性肝损伤(DILI)的研究。
HSD17B13-IN-15 (Compound 6) 作为一种有效的羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,展现出对白三烯 B3 和雌二醇的卓越抑制活性,IC50 值分别达到 ≤ 1 μM 和 ≤ 0.1 μM。该化合物主要应用于肝病、代谢性和心血管疾病的研究领域,特别适用于非酒精性脂肪肝病(NAFLD)、非酒精性脂肪性肝炎(NASH)或药物性肝损伤(DILI)的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-15 (Compound 6) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting IC 50 values of ≤ 1 μM for leukotriene B3 and ≤ 0.1 μM for estradiol. This compound finds applications in studying various conditions, including liver diseases, metabolic disorders, and cardiovascular diseases such as NAFLD, NASH, or drug-induced liver injury (DILI) [1]. |
分子量 | 428.89 |
分子式 | C21H17ClN2O4S |
CAS No. | 2758802-07-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.